Related Experiment Video

Updated: Sep 20, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.0K

New Potential Agents for Malignant Melanoma Treatment-Most Recent Studies 2020-2022

Paweł Kozyra1, Danuta Krasowska2, Monika Pitucha1

  • 1Independent Radiopharmacy Unit, Faculty of Pharmacy, Medical University of Lublin, 20-093 Lublin, Poland.

International Journal of Molecular Sciences
|June 10, 2022
PubMed

Insights

Researchers reviewed new anti-melanoma agents synthesized between 2020-2022. The study analyzes biological activity and structure-activity relationships (SAR) of novel compounds to combat malignant melanoma (MM).

Area of Science:

  • Oncology
  • Dermatology
  • Medicinal Chemistry

Background:

  • Malignant melanoma (MM) remains a lethal skin cancer with increasing incidence.
  • Therapeutic resistance and long-term treatment challenges necessitate novel anti-melanoma agents.
  • Recent advancements in drug discovery are crucial for effective MM treatment.

Purpose of the Study:

  • To review recently synthesized anti-melanoma agents (2020-2022).
  • To analyze the biological activity of novel anti-melanoma compounds.
  • To discuss the structure-activity relationship (SAR) of selected agents.

Main Methods:

  • Literature review of scientific publications from 2020-2022.
  • Selection of synthesized anti-melanoma agents.
  • Analysis of reported biological activity and SAR data.

Main Results:

  • Identification of novel synthesized anti-melanoma agents.
  • Evaluation of their anti-melanoma biological activity.
  • Discussion of SAR for key compounds, highlighting design principles.

Conclusions:

  • The review presents the latest achievements in the development of new anti-melanoma agents.
  • Understanding SAR is vital for designing more effective MM therapies.
  • Continued research into novel agents is essential to overcome treatment resistance.
Keywords:
BRAF kinaseMAPK pathwayPI3K–AKT pathwayanticancer activitycancerheterocyclic derivativesion channelsmelanomatargeted therapy

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.6K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.0K

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
677
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
523
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K